{"nctId":"NCT02041520","briefTitle":"Effect of Omega 3 Fatty Acids on Oxidative Stress in HIV Seropositive Patients","startDateStruct":{"date":"2013-01"},"conditions":["HIV/AIDS"],"count":70,"armGroups":[{"label":"Omega 3 fatty acids","type":"EXPERIMENTAL","interventionNames":["Drug: omega 3 fatty acids"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Other: placebo"]}],"interventions":[{"name":"omega 3 fatty acids","otherNames":["Zonelabs, Marblehead MA"]},{"name":"placebo","otherNames":["olive oil"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Seropositive HIV patients from 20 to 55 years old\n* On clinical score A1, A2, B1 or B2\n* Patients who received highly active antiretroviral therapy for at least 3 months.\n\nExclusion Criteria:\n\n* Patients diagnosed with diabetes mellitus\n* Patients diagnosed with hypertension\n* Patients using hypolipidemic agents or diagnosed with dyslipidemia before receiving HAART therapy.\n* Patients using protease inhibitors","healthyVolunteers":false,"sex":"ALL","minimumAge":"20 Years","maximumAge":"60 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change on Malondialdehyde After Treatment With Omega 3 Acids for 6 Months Compared With Placebo in HIV Seropositive Patients","description":null,"paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.18","spread":null},{"groupId":"OG001","value":"-0.9","spread":null}]}]}]},{"type":"SECONDARY","title":"Change on Total Glutathion After Treatment With Omega 3 Acids for 6 Months Compared With Placebo in HIV Seropositive Patients","description":null,"paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"32.9","spread":null},{"groupId":"OG001","value":"40.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Change on Nitric Oxide After Treatment With Omega 3 Acids for 6 Months Compared With Placebo in HIV Seropositive Patients","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-21.1","spread":"14.6"},{"groupId":"OG001","value":"-22.6","spread":"14.6"}]}]}]},{"type":"SECONDARY","title":"Change on Viral Load After Treatment With Omega 3 Acids for 6 Months Compared With Placebo in HIV Seropositive Patients","description":null,"paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-396","spread":null},{"groupId":"OG001","value":"90","spread":null}]}]}]},{"type":"SECONDARY","title":"Change on Oxidized- Glutathion After Treatment With Omega 3 Acids for 6 Months Compared With Placebo in HIV Seropositive Patients","description":null,"paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.1","spread":null},{"groupId":"OG001","value":"15.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Change on Reduced- Glutathion After Treatment With Omega 3 Acids for 6 Months Compared With Placebo in HIV Seropositive Patients","description":null,"paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"38.1","spread":null},{"groupId":"OG001","value":"27.9","spread":null}]}]}]},{"type":"SECONDARY","title":"Change on Alanine Aminotransferase After Treatment With Omega 3 Acids for 6 Months Compared With Placebo in HIV Seropositive Patients","description":null,"paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.0","spread":null},{"groupId":"OG001","value":"5.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Change on Aspartate Aminotransferase After Treatment With Omega 3 Acids for 6 Months Compared With Placebo in HIV Seropositive Patients","description":null,"paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.0","spread":null},{"groupId":"OG001","value":"3.0","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":35},"commonTop":["diarrhea","dizzines","biliar colic in patiet with cholelithiasis"]}}}